At BIO Europe Spring, Pharmaceutical Technology interviewed executives and investors about regional competitiveness and commercial strategy.
Eli Lilly and Insilico Medicines' AI-centric collaboration further deepens relations between the two companies, which began in 2023.
Under the agreement, Otsuka will pay $700m to Transcend shareholders upon closing.
If Recordati accepts CVC’s offer, the company will delist from the Italian Stock Exchange.
This approval will further enhance Darzalex’s penetration of the multiple myeloma market.
The FDA’s decision is based on data from the ONWARDS Phase IIIa clinical programme involving nearly 2,680 adults.
